FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology. Number of points is calculated depending on the presence of the following factors in the patient: type of tumour progression, time of recurrence after previous treatment, presence of metastases in lymph nodes, depth of tumour invasion. Further, the total score is used to determine the five-year survival rate. At 0 points, 1 degree of risk is determined, five-year survival rate – 66%; if the total score is 1-2 points, 2 degree of risk is determined, five-year survival rate – 49%; if the total score is 3-4 points, 3rd degree of risk is determined, five-year survival rate is 13%.
EFFECT: method enables determining the five-year predicted postoperative survival rate, the degree of risk of progression and death.
1 cl, 2 dwg, 5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH METASTASES IN LYMPH NODES AND OLIGOMETASTATIC DISEASE IN BONES OF SKELETON IN PROSTATE CANCER | 2018 |
|
RU2695348C2 |
A METHOD FOR PREDICTING GENERAL SURVIVABILITY IN PATIENTS WITH A CLOTHKIN TUMOR AFTER SURGICAL TREATMENT | 2016 |
|
RU2617183C1 |
METHOD OF TREATING PATIENTS WITH PROSTATE CANCER WITH LYMPHOGENOUS PROGRESSION AFTER RADICAL THERAPY METHODS | 2017 |
|
RU2681139C2 |
METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS SUFFERING FROM LIVER METASTASES OF COLORECTAL CANCER FOLLOWING HEPATIC RESECTION | 2013 |
|
RU2530610C1 |
METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS SUFFERING FROM LIVER METASTASES OF COLORECTAL CANCER FOLLOWING HEPATIC RESECTION | 2013 |
|
RU2530608C1 |
METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 |
|
RU2751818C2 |
METHOD FOR PREOPERATIVE DETERMINATION OF MORPHOLOGICAL RISK FACTORS FOR PROGRESSION IN PATIENTS WITH PROSTATE CANCER | 2021 |
|
RU2770983C1 |
METHOD FOR DETERMINING THE RISK OF RECURRENCE OF LOCALIZED PROSTATE CANCER AFTER PERFORMING HIGH-INTENSITY FOCUSED ULTRASONIC ABLATION | 2018 |
|
RU2692681C1 |
METHOD FOR PREDICTION OVERALL SURVIVAL IN PATIENTS SUFFERING LIVER METASTASES OF COLORECTAL CANCER AFTER PARTIAL HEPATECTOMY | 2013 |
|
RU2568592C2 |
METHOD FOR PREDICTION OF DEVELOPING RECURRENCE AFTER COMBINED TREATMENT OF ORAL CANCER | 2023 |
|
RU2825290C1 |
Authors
Dates
2024-07-23—Published
2024-02-08—Filed